Search Tag: cell-based therapies
2024 13 Feb
Cell-based therapies, particularly mesenchymal stromal cells (MSCs), hold significant promise for treating acute respiratory distress syndrome (ARDS). MSCs exhibit therapeutic effects such as reducing inflammation, improving lung function, and promoting tissue repair. These cells can be sourced from different tissues, affecting their ease of harvest...Read more
2022 20 Sep
Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies welcomes Barbara Ressler, Ph.D. as Vice President, Manufacturing Process Sciences. Dr. Ressler will join the executive leadership team and will be responsible for Lykan’s analytical development, process development and manufacturing...Read more